186 related articles for article (PubMed ID: 10217548)
21. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of sympathoinhibition by imidazolines.
Szabo B; Urban R
Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373
[TBL] [Abstract][Full Text] [Related]
23. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
[TBL] [Abstract][Full Text] [Related]
24. Rilmenidine reveals differences in the pharmacological characteristics of prejunctional alpha2-adrenoceptors in the guinea-pig, rat and pig.
Ali A; Cheng HY; Ting KN; Wilson VG
Br J Pharmacol; 1998 Sep; 125(1):127-35. PubMed ID: 9776352
[TBL] [Abstract][Full Text] [Related]
25. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
[TBL] [Abstract][Full Text] [Related]
26. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1999 Jun; 881():279-86. PubMed ID: 10415926
[TBL] [Abstract][Full Text] [Related]
27. Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine.
Likungu J; Molderings GJ; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):689-92. PubMed ID: 8938671
[TBL] [Abstract][Full Text] [Related]
28. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
Prichard BN; Graham BR
Drugs Aging; 2000 Aug; 17(2):133-59. PubMed ID: 10984201
[TBL] [Abstract][Full Text] [Related]
29. Interaction of rilmenidine and clonidine with pre- and postjunctional alpha-adrenoceptors in rat and rabbit blood vessels and in rat kidneys.
Verbeuren TJ; Koenig-Bérard E; Jordaens FH; Van Hoydonck AE; Verrelst J; Zonnekeyn LL; Herman AG
Arch Int Pharmacodyn Ther; 1989; 300():114-39. PubMed ID: 2575885
[TBL] [Abstract][Full Text] [Related]
30. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone.
Sannajust F; Head GA
Am J Cardiol; 1994 Dec; 74(13):7A-19A. PubMed ID: 7998588
[TBL] [Abstract][Full Text] [Related]
31. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions.
Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M
J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146
[TBL] [Abstract][Full Text] [Related]
32. Importance of imidazoline receptors in the cardiovascular actions of centrally acting antihypertensive agents.
Head GA
Ann N Y Acad Sci; 1995 Jul; 763():531-40. PubMed ID: 7677371
[TBL] [Abstract][Full Text] [Related]
33. Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbits.
Head GA; Chan CK; Godwin SJ
Neurochem Int; 1997 Jan; 30(1):37-45. PubMed ID: 9116586
[TBL] [Abstract][Full Text] [Related]
34. Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats.
Li P; Penner SB; Smyth DD
Br J Pharmacol; 1994 May; 112(1):200-6. PubMed ID: 8032642
[TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol.
Reid JL; Panfilov V; MacPhee G; Elliott HL
Ann N Y Acad Sci; 1995 Jul; 763():673-8. PubMed ID: 7677387
[TBL] [Abstract][Full Text] [Related]
36. Why imidazoline receptor modulator in the treatment of hypertension?
Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
[TBL] [Abstract][Full Text] [Related]
37. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine.
Urban R; Szabo B; Starke K
Eur J Pharmacol; 1995 Aug; 282(1-3):19-28. PubMed ID: 7498275
[TBL] [Abstract][Full Text] [Related]
38. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
[TBL] [Abstract][Full Text] [Related]
39. Imidazoline versus alpha₂-adrenoceptors in the control of gastric motility in mice.
Zádori ZS; Fehér Á; Al-Khrasani M; Lackó E; Tóth VE; Brancati SB; Hein L; Mátyus P; Gyires K
Eur J Pharmacol; 2013 Apr; 705(1-3):61-7. PubMed ID: 23499689
[TBL] [Abstract][Full Text] [Related]
40. Clonidine inhibits the canine external carotid vasodilatation to capsaicin by alpha2A/2C-adrenoceptors.
Jiménez-Mena LR; Gupta S; Muñoz-Islas E; Lozano-Cuenca J; Sánchez-López A; Centurión D; Mehrotra S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Aug; 543(1-3):68-76. PubMed ID: 16814767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
